METiS Therapeutics
PrivateLast Round
Series D
8/4/2025
Total Funding Raised
$406.8M
Momentum Score
25 /100
Company Overview
METiS Therapeutics is a biotechnology company that provides an AI-assisted platform for drug discovery and development.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical AI, ML Platforms, Quantum Computing
Business Model
B2B2C
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Infrastructure
Keywords
AI drug discoverydrug delivery optimizationdrug formulationTechBioAI biotechin silico drug discoverynucleic acid therapeuticssmall molecule therapeuticsquantum simulationmolecular dynamicsdrug discovery platformgenerative biologymRNA sequence optimizationnanodelivery platformLNP designbioavailability enhancement
Historical Pricing
Historical view of private secondary pricing and transaction trends.
METiS Therapeutics Comps
Public and private peers based on sector, stage, and business model.
METiS Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series D | 8/4/2025 | ||||
| Series C | 6/24/2024 | ||||
| Series B | 4/6/2022 | ||||
| Series A | 12/7/2021 | ||||
| Angel | 12/3/2020 | ||||
Early Funding | 12/3/2020 |
METiS Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| FundTurn Capital | Seed, Series A, Series B |
| 招银国际金融有限公司 | Series B |
| Frees Fund | Seed, Series A |
| China Life Private Equity | Series B |
| Lightspeed China Partners | Angel, Series B, Early Funding |
| 5Y Capital | Series A, Series B |
| FreesFund | Seed, Series A, Series B |
METiS Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about METiS Therapeutics's valuation, stock price, and market status.
Firmographic Details
HeadquartersCambridge, Massachusetts
Employee Range32
Year Founded2017
Last Funding8/4/2025
